Introduction. CLINICAL RESEARCH Electrocardiography and Risk Stratification. Elsayed Z. Soliman 1 *, Mostafa Abd Elsalam 2, and Yabing Li 1.

Size: px
Start display at page:

Download "Introduction. CLINICAL RESEARCH Electrocardiography and Risk Stratification. Elsayed Z. Soliman 1 *, Mostafa Abd Elsalam 2, and Yabing Li 1."

Transcription

1 Europace (2010) 12, doi: /europace/eup344 CLINICAL RESEARCH Electrocardiography and Risk Stratification The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording Elsayed Z. Soliman 1 *, Mostafa Abd Elsalam 2, and Yabing Li 1 1 Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and Prevention, Wake Forest University School of Medicine, 2000 West First Street, Piedmont Plaza 2, Suite 505, Winston-Salem, NC 27104, USA; and 2 National Heart Institute, Imbaba, Egypt Received 7 July 2009; accepted after revision 9 October 2009; online publish-ahead-of-print 3 November 2009 Aims High resting heart rate (HR) has been associated with sudden cardiac death (SCD). This association is not fully explained by the reported association between HR with coronary heart disease (CHD) or left ventricular systolic dysfunction, the major pathological substrates for SCD. Ventricular arrhythmia is the most common antecedent event before SCD. Examining associations between resting HR and ventricular arrhythmogenesis may enhance our understanding of the association between high resting HR and SCD.... Methods This study included 867 patients (age , 57% females) who underwent 24 h ambulatory electrocardiographic and results (ECG) recording (Holter) in the period from 1998 to We examined the unadjusted and multivariable-adjusted associations between resting HR with factors involved in ventricular arrhythmogenesis [ventricular late potentials (LPs) detected by signal-averaged ECG, heart rate variability (HRV), and premature ventricular complexes (PVCs)]. Linear regression models were used for continuous outcomes and logistic regression analysis was used for categorical outcomes. The multivariable models included first age and sex, then history of hypertension, diabetes, hypercholesterolaemia, CHD, heart failure, left ventricular ejection fraction (LVEF), smoking, body mass index, the use of anti-arrhythmic drugs, and ST-depression in the 24 h ambulatory ECG recording (Holter) were included in the final models. In the unadjusted and multivariable-adjusted analysis, high resting HR was significantly associated with positive ventricular LPs, depressed HRV indices, and increased prevalence of PVCs/24 h independently from demographic and clinical variables including LVEF, history of CHD, and the presence of ST-depression in Holter (P-value,0.05 in all comparisons and models).... Conclusion High resting HR is independently associated with ventricular arrhythmogenesis, the major cause of SCD. These findings could partially explain the reported association between increased HR and SCD Keywords Resting heart rate Sudden cardiac death Signal-averaged electrocardiogram Holter Heart rate variability Introduction Approximately sudden cardiac death (SCD) cases occur each year in the USA. 1,2 It has been reported that coronary heart disease (CHD) and depressed left ventricular systolic function are the major pathological substrates of SCD, and ventricular arrhythmia is by far the most common antecedent event. 3 Most of these deaths occur outside the hospitals. Therefore, using simple clinical markers to identify those at risk of SCD or its pathological basis, CHD and/or ventricular arrhythmia, is important from the prevention perspective. In this context, a high resting heart rate (HR) has been associated with both SCD and CHD The mechanistic relationship between HR and SCD, however, is not clear. Specifically, it is not known whether the association between HR and SCD is based on the association between HR with CHD and depressed left ventricular function or related to an independent association between HR and ventricular arrhythmogenesis. * Corresponding author. Tel: þ , Fax: þ , esoliman@wfubmc.edu Published on behalf of the European Society of Cardiology. All rights reserved. & The Author For permissions please journals.permissions@oxfordjournals.org.

2 262 E.Z. Soliman et al. In this study, we examined associations between high resting HR and ventricular arrhythmogenesis detected by positive ventricular late potentials (LPs) by signal-averaged ECG (SA-ECG), depressed hear rate variability (HRV), and frequency of premature ventricular complexes (PVCs) in a large sample of patients referred to ambulatory 24 h ECG recording (Holter). Better understanding of the association between HR and arrhythmogenesis could enhance our ability to choose a specific SCD preventive strategy in patients at high risk of SCD whether this could be anti-arrhythmic drugs/ devices vs. detection and correction of myocardial ischaemia/ dysfunction. Methods Study population This study included all patients who had been referred to our Holter unit for 24 h ambulatory ECG recording in the period from 1998 to Patients with poor-quality resting 12-lead ECG, patients with Holter recording,18 h, or patients with missing left ventricular ejection fraction (LVEF) data were excluded from this study (total excluded ¼ 140) leaving 867 patients for this analysis. Electrocardiography Standard 12-lead resting electrocardiogram Heart rate was determined from a 10 s long strip of lead II in a 12-lead resting ECG that was recorded the same day of Holter recording. All patients were supine and were resting at least 5 min before ECG recording. On the basis of the 10 s recording, the average RR interval (seconds) was calculated: HR ¼ (60 bpm/average RR interval). When a premature ectopic beat was included in the 10 s recording, it was included in the estimate of HR. Twenty-four-hour ambulatory electrocardiographic recording (Holter) All patients included in this analysis underwent 24 h ambulatory ECG recording (Holter). This was performed using Oxford Medilog Prima Holter management system (Oxford Medical Instruments, Old Woking, Surrey, UK) including an FD3 solid-state, three-channel recorder and prima Holter analysis software version 7.1 running under Microsoft Windows. The system has capabilities for arrhythmia, ST, SA-ECG, and HRV analyses. All recordings were analysed by a trained cardiologist. Heart rate variability Heart rate variability (HRV) indices were obtained from 24 h ambulatory ECG recordings (Holter). Non-sinus-originated beats (supraventricular and ventricular ectopic beats, AV blocks, and periods of atrial fibrillation) and artefacts were initially detected by the software and then checked and confirmed by a cardiologist. Patients with insufficient recordings (recording duration,18 h and sinus beats,50%) were excluded. Five HRV indices were calculated: 11 the standard deviation of all filtered RR intervals over the length of the recording (SDNN); mean of the standard deviations of all filtered RR intervals for all 5 min segments of the recording (SDNNi); the standard deviation of the means of all filtered RR intervals for all 5 min segments of all recording (SDANNi); the root mean square of the difference of successive RRs (RMSSD); and the percentage of RR interval that are greater than adjacent RR by 50 ms (PNN50). Signal-averaged electrocardiogram (SA-ECG) Time domain SA-ECG was used to detect ventricular LPs. QRS complexes were recorded and analysed by Oxford Medilog system (Oxford Medical Instruments). The system is designed to acquire ECG data from the 24 h ECG recording. QRS complexes in each of the three channels in a predetermined period (5 min) were averaged and filtered. The 40 Hz high pass filter was used in this study. This filter can attenuate only the low-frequency component of the sine wave,40 Hz, whereas higher frequencies are passed. The maximum noise level allowed was 0.7 mv. Ventricular LPs were considered present (positive LPs) if any two of three criteria were met: 12 (i) filtered QRS duration (QRSd).114 ms, (ii) root-mean-square voltage of the last 40 ms of the QRS complex (RMS-40),20 mv, and (iii) duration of low amplitude (,40 mv) signal of the terminal portion of the QRS (LAS).38 ms. Premature ventricular complexes Premature ventricular complexes were visually confirmed and counted per 24 h recording. Fusion beats were counted as PVCs. Nonsustained ventricular tachycardia (NSVT) defined as three or more consecutive PVCs that last no more than 30 s and terminate spontaneously was found in five patients. The number of PVCs in each of the NSVT episodes was counted towards the total number of PVCs. None of the patients had sustained ventricular tachycardia. To have a uniform comparison of the number of PVCs between groups with different ECG recording durations, we used the PVCs/24 h for comparison. This was obtained by using the formula: [(number of PVCs/duration of recording) 24]. ST-depression Significant ST-depression was defined as flat or downward sloping ST-segment shift.0.1 mv in magnitude at the J point that persisted for.1 min. Where there was pre-existing ST-depression, 0.2 mv of additional ST-depression was regarded as a significant change from baseline. Changes in T-wave vector were ignored unless accompanied by the ST-segment changes described. Other variables Demographics and history of hypertension, diabetes, CHD, heart failure, the use of anti-arrhythmic drugs, LVEF, body mass index (BMI), and smoking status were obtained from the patients health records. Statistical analysis Resting HR was categorized into quartiles. Analysis of variance and x 2 square for trend were used to compare the results of the continuous variables (mean + SD) and categorical variables (%) across quartiles of HR. We used logistic regression analysis (for categorical outcomes as the presence of ventricular LPs and ST abnormalities) and linear regression analysis (for all continuous outcomes) to estimate the multivariable-adjusted associations between 1 SD increase in HR with SA-ECG, HRV, PVCs, and ST-depression. Heart rate variability indices and the number of PVCs/24 h were logarithmically transformed in the linear regression analysis, since they showed skewed distribution. However, in the univariate analysis, we used the mean and SD of these values to allow for realistic presentation and comparison with other studies. The first set of the multivariable models was adjusted for demographic variables (age and sex). The final models included the demographic variables in the first set of models plus history of hypertension, diabetes, hypercholesterolaemia, CHD (angina, myocardial infarction, and coronary revascularization), heart failure, LVEF,

3 Heart rate and ventricular arrhythmogenesis 263 smoking, the use of anti-arrhythmic drugs, BMI, and ST-depression in the 24 h ECG recording (Holter). Results This analysis included 867 patients aged years of whom 57% were females. Patients underwent 24 h ambulatory ECG recording (Holter) with an average recording duration of 22.7 h (SD + 1.9) The prevalence of hypertension, diabetes, hypercholesterolaemia, CHD, and heart failure were 27, 17, 14, 12, and 4%, respectively. Table 1 shows the characteristics of the Table 1 Characteristics of the study population (n 5 867) a Age (years) Females 57% History of hypertension 234 (27%) History of diabetes 147 (17%) History of hypercholesterolaemia requiring 121 (14%) medications History of coronary heart disease 107 (12%) History of heart failure 39 (4%) Use of anti-arrhythmic drugs including beta-blockers 130 (15%) Smoking Current 78 (9%) Previous 295 (34%) Body mass index Left ventricular ejection fraction Mean heart rate in the 12-lead ECG a Variables are presented as either mean + SD or n (%). study population at the time of the 24 h ambulatory ECG recording (Holter). Table 2 shows the results of the HRV indices, SA-ECG measures, frequency of PVCs/24 h, and ST-depression in patients across quartiles of resting HR. As shown, all of these measures and indices were getting worse with increasing levels of the HR from the first quartile to the fourth quartile (P, for trend), i.e. HRV indices were becoming lower, whereas SA-ECG measures, the prevalence of ventricular LPs, the number of PVCs/24 h, and the prevalence of ST-depression were becoming higher with the increase in the levels of resting HR. In an age- and sex-adjusted linear regression model, 1 SD (10 bpm) increase in resting HR was significantly associated with a lower values of all HRV indices and increased number of PVCs/24 h, separately (Table 3). These statistically significant associations persisted after further adjusting for history of hypertension, diabetes, CHD, and heart failure, and also adjusting for the use of anti-arrhythmic drugs, smoking status, LVEF, BMI, and the presence of ST-depression in the 24 h ambulatory ECG recording (Holter) (P-value,0.05 in all models). Table 4 shows the odds ratios of positive ventricular LPs and ST-depression in multivariable logistic regression models adjusted first for age and sex (Model 1), and then further adjusting for history of hypertension, diabetes, CHD, heart failure, the use of anti-arrhythmic drugs, smoking status LVEF, and BMI. In the full model of ventricular LPs, ST-depression in the 24 h ambulatory ECG recording (Holter) was also included. One SD increase in resting HR was significantly associated with ventricular LPs [OR (95% CI): 1.09 (1.05, 1.14) and 1.05 (1.02, 1.08) in Models 1 and 2, respectively] and ST-depression [OR (95% CI): 1.25 (1.14, 1.39) and 1.13 (1.05, 1.21) in Models 1 and 2, respectively]. There was no statistically significant interaction between ST-depression and resting HR in models where positive ventricular LP was the outcome. Table 2 Heart rate variability indices, SA-ECG measures, frequency of PVCs/24 h, and ST-depression across quartiles of resting HR Heart rate quartiles... <67, n , n , n >93, n Heart rate variability indices SDNN (ms) SDNNi (ms) SDANNi (ms) RMSSD (ms) PNN50 (%) Signal-averaged ECG measures QRSd LAS RMS Positive ventricular LPs 20 (9%) 25 (11%) 32 (15%) 42 (21%) Premature ventricular complexes/24 h ST-depression (%) 3 (1%) 7 (3%) 8 (4%) 14 (7%) P, for analysis of variance and x 2 trend tests for all continuous and categorical variables.

4 264 E.Z. Soliman et al. Table 3 Associations between resting heart (1 SD increase a ) and HRV indices in a linear regression analysis b coefficient and 95% confidence interval... Model 1: age and sex Model 2: Model 1 1 history of hypertension, diabetes, coronary heart disease, heart failure, use of anti-arrhythmic drugs, body mass index, left ventricular ejection fraction, and smoking status... Heart rate variability indices Log SDNN (ms) (20.10, 20.28) (20.07, 20.17) Log SDNNi (ms) (20.09, 20.25) (20.04, 20.14) Log SDANNi (ms) ( ) (20.07, 20.19) Log RMSSD (ms) (20.02, 20.10) (20.01, 20.05) Log PNN (20.01, 20.05) (20.01, 20.04) Log PVCs/24 h 0.41 (0.29, 0.53) 0.32 (0.19, 0.55) a 1SD¼ 10 bpm. Table 4 Associations between resting HR (1 SD increase a ) with ST-depression and positive ventricular LPs in 24 h Holter recording in multivariable logistic regression analysis Odds ratio and 95% confidence interval... Model 1: age Model 2: Model and sex 1 1 history of hypertension, diabetes, coronary heart disease, heart failure, use of anti-arrhythmic drugs, body mass index, left ventricular ejection fraction, and smoking status... Positive 1.09 (1.05, 1.14) 1.05 (1.02, 1.08) ventricular late potentials ST-depression 1.25 (1.14, 1.39) 1.13 (1.05, 1.21) a 1SD¼ 10 bpm. Discussion The key finding of this study is that a high resting HR is associated with the arrhythmogenic substrates (expressed as positive ventricular LPs), the triggers (expressed as increased PVCs), and the predisposing electrophysiological environment (expressed as depressed HRV) of ventricular arrhythmia. In other words, high resting HR is associated with ventricular arrhythmogenesis. Such an association is independent from the association between HR with demographic and clinical variables including CHD or LVEF. From these findings, it could be suggested that the reported association between high resting HR and SCD 4 10 could be partially explained by the independent association of the earlier with ventricular arrhythmias, the major antecedent event before SCD. These findings might also explain the reported protective effect of regular exercise 13,14 and HR slowing medications in the primary and/or secondary prevention of cardiovascular disease The reported associations between life expectancy and HR 20 along with our results raise the provocative idea that various means of slowing HR might be useful in prolonging life, or at least preventing dying from SCD in patients with or without CHD. In this study, because 24 h ambulatory ECG recording (Holter) has a limited value in detecting all events of ventricular arrhythmia which could be too sporadic to be captured on only 24 h recording, we used the association between HR with the factors involved in ventricular arrhythmogenesis (ventricular LPs, HRV, and PVCs) as surrogate markers for the association between the earlier and ventricular arrhythmia. Ventricular LPs result from slowing down of the electrical transmission and losing its homogeneity across the damaged myocardial area The presence of ventricular LPs represents an anatomical substrate for repeated ventricular arrhythmia. 25 Similarly, depressed HRV indices provide the electrophysiological environment that enhances ventricular arrhythmogenesis. 11 The past two decades have witnessed growing evidence of a significant relationship between abnormalities in the cardiac autonomic neuropathy, expressed as depressed HRV indices, and SCD and non-scd Finally, PVCs provide the triggers of ventricular arrhythmia, which in the presence of appropriate arrhythmogenic substrate and electrophysiological instability can trigger repeated ventricular arrhythmia. Premature ventricular complexes have been always associated with increased mortality either SCD or non-scd. 4 The association between high resting HR with depressed ST segment as a marker of CHD (as shown in the results) could also partially explain the association between HR and SCD. These findings emphasize the importance of detection and treatment of CHD in patients at high risk of SCD. However, based on the results of this study, electrophysiological studies may be warranted in those without documented CHD and still at risk of SCD. The last notion, however, requires further examination of the association between ventricular arrhythmogenesis and high resting HR in a prospective study. The results of this study should be read in the context of some unavoidable limitations that warrant highlighting. The number of

5 Heart rate and ventricular arrhythmogenesis 265 patients with heart failure seems to be very low in this analysis. Therefore, although we adjusted for LVEF in the multivariate analysis, the results have to be interpreted with caution. Because of the inability of this study (and similar cross-sectional studies) to adjust for unrecognized confounders, it is possible that high resting HR is a surrogate for one or more unmeasured variables that may be causally linked to SCD. We tried as much as we could to adjust for all of the plausible potential confounders available to us. Further, this analysis was conducted on patients referred to the Holter unit who might be different from general population. However, those patients referred for ambulatory ECG recording (Holter) represent a group of patients who are at a higher risk for arrhythmic events or unrecognized myocardial ischaemia, in whom risk stratification for SCD and any subsequent preventive strategies would be cost-effective at least compared with general population. Another limitation that may affect the generalizability of our results is that females constituted the majority of this study population (57%). It is well known that female gender shows a higher HR in the general population. We avoided the confounding effect of the gender by adjusting for it in the multivariable. The last limitation is related to the differential ability of ambulatory ECG recording (Holter) to detect arrhythmia and ischaemia which might have resulted in less detection of ST-depression. This might have affected our conclusion that the association between HR and ventricular arrhythmogenesis is independent from CHD. To overcome such a limitation, we included history of CHD and CHD common risk factors in the models to compensate for any possible underestimation of ST-depression. In conclusion, the results of this study show that there is a significant association between high resting HR and ventricular arrhythmogenesis, an association that is independent from the association between HR and demographic and clinical variables including CHD and LVEF. These findings could partially explain the reported association between high resting HR and SCD which may call for further investigations on the effect of lowering HR as a preventive measure for SCD. Conflict of interest: none declared. References 1. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to Circulation 2001;104: Chugs SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004; 44: Myerburg RJ, Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 2006;3: Engel G, Cho S, Ghayoumi A, Yamazaki T, Chun S, Fearon WF et al. Prognostic significance of PVCS and resting heart rate. Ann Noninvasive Electrocardiol 2007;12: Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Elliott P et al. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004;147: Jouven X, Empana J, Schwartz PJ, Desnos M, Courbon D, Ducimetière P et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352: Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL et al. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ 2009;338:b Shaper AG, Wannamethee G, Macfarlane PW, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993;70: Greenland P, Martha L, Daviglus ML, Dyer AR, Liu K, Huang CF et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality. The Chicago Heart Association Detection Project In Industry. Am J Epidemiol 1999; 149: Jouven X, Schwartz PJ, Escolano S, Straczek C, Tafflet M, Desnos M et al. Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur Heart J 2009;30: Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. Heart rate variability: standards of measurements. Physiological interpretation and clinical use. Circulation 1996;93: Breithardt G, Cain M, El-sherif N, Flowers N, Hombach V, Janse M et al. Standards for analysis of ventricular late potentials using high resolution or signal averaged electrocardiography. Circulation 1991;83: Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993;328: Lee IM, Paffenbarger RS Jr, Hennekens CH. Physical activity, physical fitness and longevity. Aging (Milano) 1997;9: Kaplan JR, Manuck SB. Antiatherogenic effects of beta-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations. Am Heart J 1994; 128: Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990;65: Gundersen T, Grottum P, Pedersen T, Kjekshus JK. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 1986;58: Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F Kaplan JR, Manuck SB, Adams MR, Weingand KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987;76: Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997;30: El-Sherif N, Scherlag BJ, Lazzara R, Hope RR. Re-entrant ventricular arrhythmias in late myocardial infarction period. 1. Conduction characteristics in the infarction zone. Circulation 1977;55: Berbari EJ, Scherlag BJ, Hope RR, Lazzara R. Recording from the body surface of arrhythmogenic ventricular activity during ST segment. Am J Cardiol 1978;41: Simson MB, Euler D, Michelson EL, Falcone RA, Spear JF, Moore EN. Detection of delayed ventricular activation on the body surface in dogs. Am J Physiol 1981;241: Gardner PI, Ursell PC, Fanoglio JJ, Wit AL. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985;72: Farrell T, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED et al. Risk stratification for arrhythmic events in post-infarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18: Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death: new insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988;78: Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992;85 (Suppl. I):I Schwartz PJ. The autonomic nervous system and sudden death. Eur Heart J 1998; 19:F La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**

More information

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1 Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview

ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview Nabil El-Sherif, MD SUNY - Downstate Medical Center & New York harbor VA Healthcare System Brooklyn, NY, USA Signal Averaged ECG: A Selective

More information

Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia

Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia October 1999 513 Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia G.M. KAMALOV, A.S. GALYAVICH, N.R. KHASSANOV,

More information

ECTOPIC BEATS: HOW MANY COUNT?

ECTOPIC BEATS: HOW MANY COUNT? ECTOPIC BEATS: HOW MANY COUNT? Rupert FG Simpson, 1 Jessica Langtree, 2 *Andrew RJ Mitchell 2 1. King s College Hospital, London, UK 2. Jersey General Hospital, Jersey, UK *Correspondence to mail@jerseycardiologist.com

More information

Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction

Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction Original Article Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction Masafumi Kanemura MD, Takao Katoh MD, Takashi Tanaka MD, Shin-ichiro

More information

Noninvasive Predictors of Sudden Cardiac Death

Noninvasive Predictors of Sudden Cardiac Death 2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial

More information

The Immediate Reproducibility of T Wave Alternans During Bicycle Exercise

The Immediate Reproducibility of T Wave Alternans During Bicycle Exercise Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility

More information

Increased heart rate as a risk factor for cardiovascular disease

Increased heart rate as a risk factor for cardiovascular disease European Heart Journal Supplements (23) 5 (Supplement G), G3 G9 Increased heart rate as a risk factor for cardiovascular disease Department of Cardiology, VA Medical Center, West Los Angeles, and Department

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation J Arrhythmia Vol 25 No 1 2009 Original Article Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation Seiji Takashio

More information

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia THE VALUE OF 24 H HEART RATE VARIABILITY IN PREDICTING THE MODE OF DEATH IN PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION IN BETA-BLOCKING BLOCKING ERA Arbolishvili GN, Mareev VY Institute of Clinical

More information

Summary, conclusions and future perspectives

Summary, conclusions and future perspectives Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular

More information

12 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes: Diagnosis, Treatment and Devices. Heart Rate as a Cardiovascular Biomarker

12 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes: Diagnosis, Treatment and Devices. Heart Rate as a Cardiovascular Biomarker 12 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes: Diagnosis, Treatment and Devices Heart Rate as a Cardiovascular Biomarker Inder Anand, MD, FRCP, D Phil (Oxon.) Professor of Medicine,

More information

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole La strategia diagnostica: il monitoraggio ecg prolungato Michele Brignole ECG monitoring and syncope In-hospital monitoring Holter Monitoring External loop recorder Remote (at home) telemetry Implantable

More information

Declaration of conflict of interest. None to declare

Declaration of conflict of interest. None to declare Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece

More information

Testing the Accuracy of ECG Captured by Cronovo through Comparison of ECG Recording to a Standard 12-Lead ECG Recording Device

Testing the Accuracy of ECG Captured by Cronovo through Comparison of ECG Recording to a Standard 12-Lead ECG Recording Device Testing the Accuracy of ECG Captured by through Comparison of ECG Recording to a Standard 12-Lead ECG Recording Device Data Analysis a) R-wave Comparison: The mean and standard deviation of R-wave amplitudes

More information

MARS Ambulatory ECG Analysis The power to assess and predict

MARS Ambulatory ECG Analysis The power to assess and predict GE Healthcare MARS Ambulatory ECG Analysis The power to assess and predict Connecting hearts and minds Prevention starts with knowledge Around the world, heart disease is one of our fastest-growing health

More information

Preventing Sudden Death Current & Future Role of ICD Therapy

Preventing Sudden Death Current & Future Role of ICD Therapy Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical

More information

UNDERSTANDING YOUR ECG: A REVIEW

UNDERSTANDING YOUR ECG: A REVIEW UNDERSTANDING YOUR ECG: A REVIEW Health professionals use the electrocardiograph (ECG) rhythm strip to systematically analyse the cardiac rhythm. Before the systematic process of ECG analysis is described

More information

Heart Rate Variability in Heart Failure and Sudden Death

Heart Rate Variability in Heart Failure and Sudden Death Heart Rate Variability in Heart Failure and Sudden Death Phyllis K. Stein, PhD Washington University School of Medicine St. Louis, MO Outline Effect of erratic rhythm and sinus bigemeny on HRV. Traditional,

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

Study Day 1 Study Days 2 to 9 Sequence 1 Placebo for moxifloxacin Study Days 2 to 8: placebo for pazopanib (placebopaz) 800 mg;

Study Day 1 Study Days 2 to 9 Sequence 1 Placebo for moxifloxacin Study Days 2 to 8: placebo for pazopanib (placebopaz) 800 mg; The study listed may include approved non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Methods. Washington, DC and Hines, Illinois

Methods. Washington, DC and Hines, Illinois 942 JACC Vol. 32, No. 4 Prevalence and Significance of Nonsustained Ventricular Tachycardia in Patients With Premature Ventricular Contractions and Heart Failure Treated With Vasodilator Therapy STEVEN

More information

A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome

A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A. Tolat A. Statement of study rationale and purpose T wave alternans (TWA), an alteration of the amplitude

More information

Ventricular ectopic activity after premature atrial beats

Ventricular ectopic activity after premature atrial beats British Heart Journal, 1977, 39, 1033-1037 Ventricular ectopic activity after premature atrial beats in acute myocardial infarction1 R. J. MYERBURG, R. J. SUNG, G. GERSTENBLITH, STEPHEN M. MALLON, AND

More information

Heart rate: an independent risk factor in cardiovascular disease

Heart rate: an independent risk factor in cardiovascular disease European Heart Journal Supplements (2007) 9 (Supplement F), F3 F7 doi:10.1093/eurheartj/sum030 Heart rate: an independent risk factor in cardiovascular disease Åke Hjalmarson The Wallenberg Laboratory

More information

Remote Monitoring & the Smart Home of the 21 Century

Remote Monitoring & the Smart Home of the 21 Century Cardiostim EHRA Europace 2016, Nice - June 8-11, 2016 Remote Monitoring & the Smart Home of the 21 Century Antonio Raviele, MD, FESC, FHRS President ALFA -Alliance to Fight Atrial fibrillation- Venezia

More information

4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J.

4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. Wellens MD 1 Einthoven, 1905 The ECG! Everywhere available! Easy and rapid

More information

Volume 141, UTILITY OF SHORT-TERM HEART RATE VARIABILITY FOR PREDICTION OF SUDDEN CARDIAC DEATH AFTER ACUTE MYOCARDIAL INFARCTION

Volume 141, UTILITY OF SHORT-TERM HEART RATE VARIABILITY FOR PREDICTION OF SUDDEN CARDIAC DEATH AFTER ACUTE MYOCARDIAL INFARCTION Volume 141, 1998 69 UTILITY OF SHORT-TERM HEART RATE VARIABILITY FOR PREDICTION OF SUDDEN CARDIAC DEATH AFTER ACUTE MYOCARDIAL INFARCTION Josef Kautzner a, Petr Šťovíček b, Zdeněk Anger b, Jarmila Šavlíková

More information

Practice Name Practice Address Practice Address 2 Practice Phone Number

Practice Name Practice Address Practice Address 2 Practice Phone Number HOLTER REPORT Practice Name Practice Address Practice Address 2 Practice Phone Number Name: Sample 3CH, AfibFlutter Recording Start Date/Time: 8/12/212 9:5:57 PM D: 937452 Date Of Birth: 5/18/1949 Secondary

More information

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators Journal of the American College of Cardiology Vol. 53, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.10.053

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: signal_averaged_ecg 7/1992 10/2017 10/2018 10/2017 Description of Procedure or Service Signal-averaged electrocardiography

More information

Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls

Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls 672 Acta Cardiol 2015; 70(6): 672-677 doi: 10.2143/AC.70.6.3120179 [ Original article ] Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls

More information

HRV ventricular response during atrial fibrillation. Valentina Corino

HRV ventricular response during atrial fibrillation. Valentina Corino HRV ventricular response during atrial fibrillation Outline AF clinical background Methods: 1. Time domain parameters 2. Spectral analysis Applications: 1. Evaluation of Exercise and Flecainide Effects

More information

Exercise treadmill testing is frequently used in clinical practice to

Exercise treadmill testing is frequently used in clinical practice to Preventive Cardiology FEATURE Case Report 55 Commentary 59 Exercise capacity on treadmill predicts future cardiac events Pamela N. Peterson, MD, MSPH 1-3 David J. Magid, MD, MPH 3 P. Michael Ho, MD, PhD

More information

ECG Interpretation Made Easy

ECG Interpretation Made Easy ECG Interpretation Made Easy Dr. A Tageldien Abdellah, MSc MD EBSC Lecturer of Cardiology- Hull University Hull York Medical School 2007-2008 ECG Interpretation Made Easy Synopsis Benefits Objectives Process

More information

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11 Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias Markus Kowalsky Group 11 Selected Paper Ventricular arrhythmia is predicted by sum absolute QRST integral but not

More information

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Pacing in Drug Testing

Pacing in Drug Testing ISHNE International Society for Holter and Noninvasive Electrocardiology 1 st Worldwide Internet Symposium on Drug- Induced QT Prolongation October 1-15, 1 15, 2007 Pacing in Drug Testing I Savelieva,

More information

CME Article Brugada pattern masking anterior myocardial infarction

CME Article Brugada pattern masking anterior myocardial infarction Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University

More information

JSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE»

JSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE» JSC «Astana Medical University» PhD THESIS ANNOTATION Specialty: 6D110100 «MEDICINE» Title: «Prognostic efficiency of sudden cardiac death s predictors in preserved and moderately reduced left ventricle

More information

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,

More information

HRV and Risk Stratification: Post-MI. Phyllis K. Stein, Ph.D. Washington University School of Medicine St. Louis, MO

HRV and Risk Stratification: Post-MI. Phyllis K. Stein, Ph.D. Washington University School of Medicine St. Louis, MO HRV and Risk Stratification: Post-MI Phyllis K. Stein, Ph.D. Washington University School of Medicine St. Louis, MO Outline Research vs. clinical Holter scanning. Caveats in interpretation of published

More information

TO DETERMINE WHETHER THE SURVIVAL BENEFITS OF β-blockade IN ACUTE CORONARY EVENTS IS ASSOCIATED WITH THE MAGNITUDE OF

TO DETERMINE WHETHER THE SURVIVAL BENEFITS OF β-blockade IN ACUTE CORONARY EVENTS IS ASSOCIATED WITH THE MAGNITUDE OF TO DETERMINE WHETHER THE SURVIVAL BENEFITS OF β-blockade IN ACUTE CORONARY EVENTS IS ASSOCIATED WITH THE MAGNITUDE OF HEART RATE REDUCTION OR IS SIGNIFICANTLY BETTER BELOW A GIVEN TARGET HEART RATE by

More information

Electrocardiographic Recording

Electrocardiographic Recording Spontaneous Variability of Complex Ventricular Arrhythmias Detected by Long-term Electrocardiographic Recording ERIC L. MICHELSON, M.D., AND JOEL MORGANROTH, M.D. SUMMARY Variations in the frequency of

More information

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off

More information

ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director

ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director December 2018 ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director To obtain best results Select Slide Show from the ribbon at the top of your PowerPoint screen Select From Beginning on the

More information

at least 4 8 hours per week

at least 4 8 hours per week ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual

More information

physiology 6 Mohammed Jaafer Turquoise team

physiology 6 Mohammed Jaafer Turquoise team 15 physiology 6 Mohammed Jaafer 22-3-2016 Turquoise team Cardiac Arrhythmias and Their Electrocardiographic Interpretation Today, we are going to talk about the abnormal excitation. As we said before,

More information

CASE 10. What would the ST segment of this ECG look like? On which leads would you see this ST segment change? What does the T wave represent?

CASE 10. What would the ST segment of this ECG look like? On which leads would you see this ST segment change? What does the T wave represent? CASE 10 A 57-year-old man presents to the emergency center with complaints of chest pain with radiation to the left arm and jaw. He reports feeling anxious, diaphoretic, and short of breath. His past history

More information

Bernard Belhassen, MD; Roman Fish, MD; Sami Viskin, MD; Aharon Glick, MD; Michael Glikson, MD; Michael Eldar, MD

Bernard Belhassen, MD; Roman Fish, MD; Sami Viskin, MD; Aharon Glick, MD; Michael Glikson, MD; Michael Eldar, MD www.ipej.org 3 Original Article Incidence of Dual AV Node Physiology Following Termination of AV Nodal Reentrant Tachycardia by Adenosine-5'-Triphosphate: A Comparison with Drug Administration in Sinus

More information

The mortality of high-risk patients surviving myocardial

The mortality of high-risk patients surviving myocardial Arrhythmia/Electrophysiology Prevalent Low-Frequency Oscillation of Heart Rate Novel Predictor of Mortality After Myocardial Infarction Dan Wichterle, MD; Jan Simek, MD; Maria Teresa La Rovere, MD; Peter

More information

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol Clinical Features FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol History: Progressive disease, characterised by the following clinical stages: o Early concealed phase

More information

HRV in Diabetes and Other Disorders

HRV in Diabetes and Other Disorders HRV in Diabetes and Other Disorders Roy Freeman, MD Center for Autonomic and Peripheral Nerve Disorders Beth Israel Deaconess Medical Center Harvard Medical School Control Propranolol Atropine Wheeler

More information

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD The Electrocardiogram part II Dr. Adelina Vlad, MD PhD Basic Interpretation of the ECG 1) Evaluate calibration 2) Calculate rate 3) Determine rhythm 4) Determine QRS axis 5) Measure intervals 6) Analyze

More information

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology

More information

Pathfinder Holter Analyzer CARDIAC DIAGNOSTIC SOLUTIONS

Pathfinder Holter Analyzer CARDIAC DIAGNOSTIC SOLUTIONS Pathfinder Holter Analyzer CARDIAC DIAGNOSTIC SOLUTIONS Pathfinder Digital - An Evolution... Del Mar Reynolds rich history of innovation began nearly a half century ago with the development of Holter monitoring

More information

Presenter Disclosure Information

Presenter Disclosure Information Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic

More information

Supplemental Material

Supplemental Material Supplemental Material Supplemental Results The baseline patient characteristics for all subgroups analyzed are shown in Table S1. Tables S2-S6 demonstrate the association between ECG metrics and cardiovascular

More information

Lecture outline. Electrical properties of the heart. Automaticity. Excitability. Refractoriness. The ABCs of ECGs Back to Basics Part I

Lecture outline. Electrical properties of the heart. Automaticity. Excitability. Refractoriness. The ABCs of ECGs Back to Basics Part I Lecture outline The ABCs of ECGs Back to Basics Part I Meg Sleeper VMD, DACVIM (cardiology) University of Florida Veterinary School Electrical properties of the heart Action potentials Normal intracardiac

More information

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University J Wave Syndromes Osama Diab Lecturer of Cardiology Ain Shams University J Wave Syndromes Group of electric disorders characterized by > 1 mm elevation of the J point or prominent J wave with or without

More information

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning based ECG practice E-book REtrive REpeat RElearn Design by S I T T I N U N T H A N G J U I P E E R I Y A W A

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

Heart-rate Variability Christoph Guger,

Heart-rate Variability Christoph Guger, Heart-rate Variability Christoph Guger, 10.02.2004 Heart-rate Variability (HRV) 1965 Hon & Lee Fetal distress alterations in interbeat intervals before heart rate (HR) changed 1980 HRV is strong and independent

More information

ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE)

ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) ATRIAL FIBRILLATION AND ETHNICITY Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) Atrial fibrillation (AF) and ethnicity The known The unknown The paradox Why

More information

AUTOMATIC ANALYSIS AND VISUALIZATION OF MULTILEAD LONG-TERM ECG RECORDINGS

AUTOMATIC ANALYSIS AND VISUALIZATION OF MULTILEAD LONG-TERM ECG RECORDINGS AUTOMATIC ANALYSIS AND VISUALIZATION OF MULTILEAD LONG-TERM ECG RECORDINGS Vessela Tzvetanova Krasteva 1, Ivo Tsvetanov Iliev 2 1 Centre of Biomedical Engineering Prof. Ivan Daskalov - Bulgarian Academy

More information

Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community. The Framingham Heart Study

Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community. The Framingham Heart Study Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community The Framingham Heart Study Ali Morshedi-Meibodi, MD; Jane C. Evans, DSc; Daniel Levy, MD;

More information

HEART-RATE RECOVERY IMMEDIATELY AFTER EXERCISE AS A PREDICTOR OF MORTALITY HEART-RATE RECOVERY IMMEDIATELY AFTER EXERCISE AS A PREDICTOR OF MORTALITY

HEART-RATE RECOVERY IMMEDIATELY AFTER EXERCISE AS A PREDICTOR OF MORTALITY HEART-RATE RECOVERY IMMEDIATELY AFTER EXERCISE AS A PREDICTOR OF MORTALITY HEART-RATE RECOVERY IMMEDIATELY AFTER EXERCISE AS A PREDICTOR OF MORTALITY CHRISTOPHER R. COLE, M.D., EUGENE H. BLACKSTONE, M.D., FREDRIC J. PASHKOW, M.D., CLAIRE E. SNADER, M.A., AND MICHAEL S. LAUER,

More information

MEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS

MEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

Sudden Cardiac Death: Definitions

Sudden Cardiac Death: Definitions Contemporary Epidemiology of Sudden Death: Insights from the Comprehensive UCSF SCD Study 23 October 2010 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor of

More information

P atients with unstable angina or non-st elevation myocardial

P atients with unstable angina or non-st elevation myocardial 36 CARDIOVASCULAR MEDICINE Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers S Kennon, C P Price, P G Mills, P K MacCallum, J Cooper, J Hooper,

More information

ORIGINAL INVESTIGATION. Ventricular Arrhythmias During Clinical Treadmill Testing and Prognosis

ORIGINAL INVESTIGATION. Ventricular Arrhythmias During Clinical Treadmill Testing and Prognosis ORIGINAL INVESTIGATION Ventricular Arrhythmias During Clinical Treadmill Testing and Prognosis Frederick E. Dewey, BA; John R. Kapoor, MD, PhD; Ryan S. Williams, MD; Michael J. Lipinski, MD; Euan A. Ashley,

More information

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski Cardiac arrhythmias Janusz Witowski Department of Pathophysiology Poznan University of Medical Sciences A 68-year old man presents to the emergency department late one evening complaining of increasing

More information

Signal-Averaged Electrocardiography (SAECG)

Signal-Averaged Electrocardiography (SAECG) Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are

More information

Diploma in Electrocardiography

Diploma in Electrocardiography The Society for Cardiological Science and Technology Diploma in Electrocardiography The Society makes this award to candidates who can demonstrate the ability to accurately record a resting 12-lead electrocardiogram

More information

My Patient Needs a Stress Test

My Patient Needs a Stress Test My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction

More information

Electrocardiography Biomedical Engineering Kaj-Åge Henneberg

Electrocardiography Biomedical Engineering Kaj-Åge Henneberg Electrocardiography 31650 Biomedical Engineering Kaj-Åge Henneberg Electrocardiography Plan Function of cardiovascular system Electrical activation of the heart Recording the ECG Arrhythmia Heart Rate

More information

ORIGINAL ARTICLE. STUDY OF ARRHYTHMIAS IN ACUTE INFERIOR WALL MYOCARDIAL INFARCTION Ravikumar T. N 1, Anikethana G. V 2

ORIGINAL ARTICLE. STUDY OF ARRHYTHMIAS IN ACUTE INFERIOR WALL MYOCARDIAL INFARCTION Ravikumar T. N 1, Anikethana G. V 2 STUDY OF ARRHYTHMIAS IN ACUTE INFERIOR WALL MYOCARDIAL INFARCTION Ravikumar T. N 1, Anikethana G. V 2 HOW TO CITE THIS ARTICLE: Ravikumar T. N, Anikethana G. V. Study of Arrhythmias in Acute Inferior Wall

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Signal Processing of Stress Test ECG Using MATLAB

Signal Processing of Stress Test ECG Using MATLAB Signal Processing of Stress Test ECG Using MATLAB Omer Mukhtar Wani M. Tech ECE Geeta Engineering College, Panipat Abstract -Electrocardiography is used to record the electrical activity of the heart over

More information

Ripolarizzazione precoce. Torino, 24th October Non così innocente come si pensava

Ripolarizzazione precoce. Torino, 24th October Non così innocente come si pensava Asymptomatic inherited arrhythmia syndromes: Drug induced Brugada Syndrome: when a prophylactic ICD is indicated? how high (or low) is QT the risk? Asymptomatic short Ripolarizzazione precoce. Torino,

More information

Diagnostic capabilities of the implantable therapeutic systems

Diagnostic capabilities of the implantable therapeutic systems Cardiac pacing 2012 and beyound Monday August 27, 2012 Diagnostic capabilities of the implantable therapeutic systems Pekka Raatikainen Heart Center Co. Tampere University Hospital and University of Tampere

More information

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

More information

Are there low risk patients in Brugada syndrome?

Are there low risk patients in Brugada syndrome? Are there low risk patients in Brugada syndrome? Pedro Brugada MD, PhD Andrea Sarkozy MD Risk stratification in Brugada syndrome In the last years risk stratification in Brugada syndrome has become the

More information

USING CORRELATION COEFFICIENT IN ECG WAVEFORM FOR ARRHYTHMIA DETECTION

USING CORRELATION COEFFICIENT IN ECG WAVEFORM FOR ARRHYTHMIA DETECTION BIOMEDICAL ENGINEERING- APPLICATIONS, BASIS & COMMUNICATIONS USING CORRELATION COEFFICIENT IN ECG WAVEFORM FOR ARRHYTHMIA DETECTION 147 CHUANG-CHIEN CHIU 1,2, TONG-HONG LIN 1 AND BEN-YI LIAU 2 1 Institute

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

What Every Physician Should Know:

What Every Physician Should Know: What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer

More information

Value of the P-Wave Signal-Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery

Value of the P-Wave Signal-Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery 2618 Value of the P-Wave Signal-Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery Jonathan S. Steinberg, MD; Steven Zelenkofske, DO; Shing-Chiu Wong, MD; Mark Gelernt, MD; Robert Sciacca,

More information

Prevalence and QT Interval of Early Repolarization. in a Hospital-based Population

Prevalence and QT Interval of Early Repolarization. in a Hospital-based Population Original Article in a Hospital-based Population Hideki Hayashi MD PhD, Akashi Miyamoto MD, Katsuya Ishida MD, Tomohide Yoshino MD, Yoshihisa Sugimoto MD PhD, Makoto Ito MD PhD, Minoru Horie MD PhD Department

More information

file://c:\documents and Settings\admin\My Documents\CV\92.htm

file://c:\documents and Settings\admin\My Documents\CV\92.htm Page 1 of 5 Amir Farjam Fazelifar, M.D. Assistant Professor of Cardiac Electrophysiology Academic Address: Shaheed Rajaei Cardiovascular, Medical & Research Center, Vali- Asr Avenue Tehran- Iran Tel /

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tseng ZH, Hayward RM, Clark NM, et al. Sudden death in patients with cardiac implantable electronic devices. JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2641.

More information

Pause-induced Ventricular Tachycardia: Clinical Characteristics

Pause-induced Ventricular Tachycardia: Clinical Characteristics Pause-induced Ventricular Tachycardia: Clinical Characteristics Margaret Bond A. Study Purpose and Rationale Until three decades ago, ventricular arrhythmias were thought to be rare in occurrence and their

More information

Signal-Averaged Electrocardiography

Signal-Averaged Electrocardiography 238 JACC Vol. 27, No. 1 ACC EXPERT CONSENSUS DOCUMENT Signal-Averaged Electrocardiography MICHAEL E. CAIN, MD, FACC, CHAIR JEFFREY L. ANDERSON, MD, FACC MORTON F. ARNSDORF, MD, FACC COMMITTEE MEMBERS JAY

More information

Prevention of Sudden Death in ARVC

Prevention of Sudden Death in ARVC ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück

More information